Month: February 2019

Lexington Biosciences Announces Termination of Private Placement

VANCOUVER, British Columbia, Feb. 14, 2019 — Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”) announces that, despite numerous attempts over the past 9 months, it has been unable to secure the necessary funding to advance the development of its HeartSentry technology. As a result, the Company is terminating its previously announced private placement

Read More



Newsletter Updates

If you haven’t already done so, signup here to receive future editions and the latest company news direct to your inbox.

Latest News